Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's Ozempic may modestly reduce the risk of obesity-related ...

For a limited time, Wegovy will be available to new patients at $199 for the first month, Novo Nordisk said Thursday.

For a limited time, Wegovy will be available to new patients at $199 for the first month, Novo Nordisk said Thursday.

Starting today, pharmacies can no longer make cheaper alternatives to popular weight loss drugs, driving up costs for ...

Novo Nordisk reduces its starter dose prices through telehealth platforms to encourage weaning patients off compounded copycats.

News last week that a CNN investigative report found dozens of fake podcasts on the popular audio streaming and media service platform Spotify, illegally ...

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...